Tornier, which makes orthopedic implants for upper and lower extremity joints, will see its quiet period end on Monday, March 14. On February 2, the company raised $166 million by offering 8.75 million shares at $19, at the low end of the range of $19 to $21. BofA Merrill Lynch and J.P. Morgan acted as lead managers on the deal.
